Hirschsprung-like disease is exacerbated by reduced de novo GMP synthesis

Authors

Jonathan I. Lake, Washington University School of Medicine in St. Louis
Olga A. Tusheva, Washington University School of Medicine in St. Louis
Brittany L. Graham, Washington University School of Medicine in St. Louis
Robert O. Heuckeroth, Washington University School of Medicine in St. Louis

Journal

The Journal of Clinical Investigation

Publication Date

2013

Volume

123

Issue

11

Inclusive Pages

4875-4887

Document Type

Open Access Publication

DOI

10.1172/JCI69781

Rights and Permissions

Hirschsprung-like disease is exacerbated by reduced de novo GMP synthesis Jonathan I. Lake, Olga A. Tusheva, Brittany L. Graham, Robert O. Heuckeroth Published in Volume 123, Issue 11 J Clin Invest. 2013; 123(11):4875–4887 doi:10.1172/JCI69781

Recommended Citation

Lake, Jonathan I.; Tusheva, Olga A.; Graham, Brittany L.; and Heuckeroth, Robert O., "Hirschsprung-like disease is exacerbated by reduced de novo GMP synthesis." The Journal of Clinical Investigation. 123, 11. 4875-4887. (2013).
https://digitalcommons.wustl.edu/open_access_pubs/2691